PRMT5 inhibition induces ferroptosis and enhances immunotherapy efficacy in renal cell carcinoma
Ferroptosis, a regulated cell death mechanism, is emerging as a promising target for cancer therapy. The process is mediated by the activity of acyl-CoA synthetase